Barriers and Facilitators for Vancomycin Reduction in Preterm Infants: A Survey of Neonatal Clinicians

Pooja S. Yerram, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Hanna Rosewood, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Michael W. Kuzniewicz, Kaiser Permanente Northern California, Los Gatos, CA, United States; Jeffrey S. Gerber, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Karen M. Puopolo, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States; Julia E.. Szymczak, University of Utah School of Medicine, Salt Lake City, UT, United States; Melissa Schmatz, Children's Hospital of Philadelphia, Philadelphia, PA, United States; Chris Bonafide, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Canita R.. Brent, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Lori Christ, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; El Noh, Children’s Hospital of Philadelphia, West Chester, PA, United States; Catherine K. Muhumuza, PennMedicine at Princeton University Hospital, Plainsboro, NJ, United States; Alina Ivashchuk, Women’s and Babies Hospital/Penn Medicine, Lancaster, PA, United States; Crystal Bass, CHOP Newborn Care at AtlantiCare, Galloway, NJ, United States; Joshua Bress, Global Strategies, Albany, CA, United States; Catherine Myers, Childrens Hospital of Philadelphia, Pomona, NJ, United States; Miren B. Dhudasia, Childrens Hospital of Philadelphia, Philadelphia, PA, United States; Samuel Garber, Perelman School of Medicine at the University of Pennsylvania, Voorhees, NJ, United States; Sagori Mukhopadhyay, Childrens Hospital of Philadelphia, Philadelphia, PA, United States